Krka with €101.8 mln net profit in H1

Slovenian pharmaceutical company Krka reported H1 consolidated net profit of €101.8 million compared to €91.7 million y/y. Operating profit stood at €135.5 million versus €124.1 million in H1 2017.  EBITDA grew to €190.9 million from  €177.3 million y/y. Consolidated revenue in H1 rose to  €680.5 million from €655.1 million a year ago. Krka has been listed on Warsaw Stock Exchange from 2012….

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It